Want to join the conversation?
$AMGN and $ARWR announced two agreements to develop and commercialize RNA interference (RNAi) therapies for cardiovascular disease. Under one agreement, $AMGN receives a worldwide, exclusive license to $ARWR's RNAi ARC-LPA program. These RNAi molecules are designed to reduce elevated lipoprotein, which is a risk factor for cardiovascular disease.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.